Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Obstet Gynaecol India ; : 1-7, 2022 Sep 22.
Article in English | MEDLINE | ID: covidwho-2260175

ABSTRACT

Background: Whether vertical transmission or placental pathology occurs after maternal infection during pregnancy remains unknown. There is a clear need for studies on the impact of COVID-19 on pregnancy outcome. A systemic inflammatory or hypercoagulable state may be the contributing factor for placental pathology. Methods: The pregnant women with COVID-19 who delivered between May 2020 and May 2021 were followed and data were collected about pregnancy course and placentas were examined for macro- and microscopical changes and were compared to controls with non-infected women. Results: Placenta of COVID-19-infected females had increased prevalence of decidual arteriopathy and placental injury reflecting hypoxia and uteroplacental insufficiency within the intervillous space. Features of maternal vascular malperfusion such as increased syncytial knots were present in 100% cases. Fibrinoid necrosis was seen in 100% cases and increased focal perivillous fibrin depositions were presented in 37.7% cases. About one fourth infected placentas had evidence of villitis. Even after matching for comorbidities like preeclampsia, these changes were present. Conclusion: The most common pathological findings of the placenta of COVID-19 infections are signs of maternal and fetal malperfusion. Future studies should target infections in different stage of gestation, including first and second trimesters.

2.
J Pak Med Assoc ; 72(4): 795, 2022 04.
Article in English | MEDLINE | ID: covidwho-2026786
3.
ISA Trans ; 124: 69-81, 2022 May.
Article in English | MEDLINE | ID: covidwho-1851352

ABSTRACT

World is facing stress due to unpredicted pandemic of novel COVID-19. Daily growing magnitude of confirmed cases of COVID-19 put the whole world humanity at high risk and it has made a pressure on health professionals to get rid of it as soon as possible. So, it becomes necessary to predict the number of upcoming cases in future for the preparation of future plan-of-action and medical set-ups. The present manuscript proposed a hybrid fuzzy time series model for the prediction of upcoming COVID-19 infected cases and deaths in India by using modified fuzzy C-means clustering technique. Proposed model has two phases. In phase-I, modified fuzzy C-means clustering technique is used to form basic intervals with the help of clusters centroid while in phase-II, these intervals are upgraded to form sub-intervals. The proposed model is tested against available COVID-19 data for the measurement of its performance based on mean square error, root mean square error and average forecasting error rate. The novelty of the proposed model lies in the prediction of COVID-19 infected cases and deaths for next coming 31 days. Beside of this, estimation for the approximate number of isolation beds and ICU required has been carried out. The projection of the present model is to provide a base for the decision makers for making protection plan during COVID-19 pandemic.


Subject(s)
COVID-19 , COVID-19/epidemiology , Forecasting , Humans , India/epidemiology , Pandemics/prevention & control , Time Factors
4.
Mathematical Problems in Engineering ; : 1-22, 2022.
Article in English | Academic Search Complete | ID: covidwho-1752938

ABSTRACT

The outbreak of COVID-19 has become a global pandemic as announced by World Health Organisation. As India has already met the two waves, named first and second wave, it is assumed that COVID-19 will again strike in India in the form of third wave. The peak during the upcoming third wave and determination of the approximated maximum number of COVID-19 infected cases and deaths at a particular day becomes crucial for India. To determine the peak of infectious curve, this article proposed a hybrid fuzzy time series forecasting model based on particle swarm optimization and fuzzy c-mean technique, named as fuzzy time series particle swarm optimization extended fuzzy c-mean technique. The proposed model works in two phases. In phase-I, particle swarm optimization extended fuzzy c-mean method is used to form initial intervals with the help of centroids, while in phase-II, these intervals are updated to form subintervals. In the present article, a fitness function is developed for particle swarm optimization to increase its convergence speed and basic fuzzy c-mean is extended by using an exponential function to tolerate the effect of outliers, named as extended fuzzy c-mean technique. The effectiveness of the proposed model has been tested based on mean square error and root mean square error on first and second wave COVID-19 data, and the obtained results are very close to the existing data of COVID-19 with less error rate. Thus, the proposed model is suitable to forecast a better approximation value of COVID-19 infected cases and deaths in India during the upcoming third wave. This study demonstrates that third wave of COVID-19 could occur in India, while also illustrating that it is unlikely for any such resurgence to be as large as the second wave. The proposed model predicts that the peak of third wave will occur approximately after 40–70 days from the mid of December. Furthermore, the impact of vaccination on infected cases and deaths during the upcoming third wave in India is also studied. With the implementation of the vaccine on the Indian people, the peak of COVID-19 infected during third wave will be shifted in forward direction. On the basis of the proposed model, government authorities will be enabling to know expected required resources such as hospital patient beds, ICU beds, and oxygen concentrators during the upcoming outspread of COVID-19 like disease in future. [ FROM AUTHOR] Copyright of Mathematical Problems in Engineering is the property of Hindawi Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

5.
Trop Med Health ; 49(1): 82, 2021 Oct 13.
Article in English | MEDLINE | ID: covidwho-1468111

ABSTRACT

Zika virus remains endemic and opportunistic of high transmission in the tropical region of Africa, and the repeated cases of the Zika virus in Africa made it public health emergency in 2016. Amidst the COVID-19 pandemic, the catastrophic cases of unknown and unreported deaths overwhelming the region of Africa could not give health attention to respond to other endemic diseases. Here, we present the possible complication and challenges associated with the Zika virus in Africa and COVID-19 predominance, shifting the attention from the Zika virus surveillance. This paper determines to enlighten the reader about the situation, the efforts to curb the transmission of both the Zika virus and the COVID-19 pandemic. Therefore, the report recommends sustainable solutions that can lessen the threat to public health.

6.
Indian J Pathol Microbiol ; 63(3): 350-357, 2020.
Article in English | MEDLINE | ID: covidwho-706335

ABSTRACT

Declared as a pandemic by WHO on March 11, 2020, COVID-19 has brought about a dramatic change in the working of different laboratories across the country. Diagnostic laboratories testing different types of samples play a vital role in the treatment management. Irrespective of their size, each laboratory has to follow strict biosafety guidelines. Different sections of the laboratory receive samples that are variably infectious. Each sample needs to undergo a proper and well-designed processing system so that the personnel involved are not infected and also their close contacts. It takes a huge effort so as to limit the risk of exposure of the working staff during the collection, processing, reporting or dispatching of biohazard samples. Guidelines help in preventing the laboratory staff and healthcare workers from contracting the disease which has a known human to human route of transmission and high rate of mortality. A well-knit approach is the need of the hour to combat this fast spreading disease. We anticipate that the guidelines described in this article will be useful for continuing safe work practices by all the laboratories in the country.


Subject(s)
Containment of Biohazards/methods , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Occupational Exposure/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Specimen Handling/methods , Betacoronavirus , COVID-19 , Disinfection/methods , Guidelines as Topic , Hazardous Substances , Health Personnel/standards , Humans , Laboratories/standards , Pathologists/standards , SARS-CoV-2 , Waste Management/methods
SELECTION OF CITATIONS
SEARCH DETAIL